2019 Doctors Leads 
World of DTC Marketing
JULY 21, 2022
Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. According to a 2019 study from Kantar , a whopping 70 percent of consumers say they see the same ads over and over again. It’s not more T.V. Running T.V.
World of DTC Marketing
JUNE 14, 2022
years in 2019 to 76.99 In contrast, peer countries averaged a smaller decrease in life expectancy between 2019 and 2020 (0.57 Heart disease is the nation’s leading killer, and diabetes and obesity are twin epidemics, as rates of both have climbed in recent years. US life expectancy decreased from 78.86 years) and a 0.28-year
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
AUGUST 9, 2021
HCPs are also connecting more than ever: one study showed that HCP posts about healthcare increased from 10% in 2013 to 50% in 2019. A leading pharma company recently sponsored a series of Q&A around the use of their new cancer drug. 33 Even now, nearly 70% of all HCPs are digital natives.
World of DTC Marketing
AUGUST 16, 2022
Annual obesity-related medical care costs in the United States, in 2019 dollars, were estimated to be nearly $173 billion. A New York Times article said, “Poor diet is the leading cause of mortality in the U.S.” It leads to a lack of accountability. An analysis predicts that by 2030, 48.9% will be severely obese.
World of DTC Marketing
DECEMBER 2, 2020
SUMMARY: Both emergency room visits and doctors’ visits are down by about half because people are putting off treatment for medical emergencies due to fears of contracting COVID-19. How is pharma going to get patients back into to ask their doctor about branded medications? This is especially true for undiagnosed patients.
World of DTC Marketing
JUNE 22, 2022
Between 2019 and 2021, Alphabet’s venture-capital arms, Google Ventures, and Gradient Ventures, and its private-equity unit, CapitalG, made about 100 deals, a quarter of Alphabet’s combined total, in life sciences and health care. Google launched itself into the wearables business in 2019 with a $2.1bn acquisition of Fitbit.
World of DTC Marketing
JUNE 1, 2021
Too many doctors, the data was still questionable. After aducanumab showed promise in 2016, Biogen launched two late-stage trials — then stopped them halfway through, in March 2019, when an analysis concluded the studies would not reach their goal of slowing cognitive and functional impairment in participants.
Expert insights. Personalized for you.
266 
Let's personalize your content